Title:
【発明の名称】HIVプロテアーゼ阻害剤
Document Type and Number:
Japanese Patent JP3000564
Kind Code:
B2
Abstract:
Compounds of formula (I) are HIV protease inhibitors. These compounds are useful in the prevention or treatment of infection by HIV and in the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
More Like This:
| WO/2010/029995 | THERAPEUTIC AGENT FOR PAIN |
| JP6967054 | FLT3 receptor antagonist |
| WO/1997/030044 | QUINAZOLINE COMPOUNDS |
Inventors:
Huff, Joel Earl
Batka, Joseph Py
Dorsey, Bruce Day
Batka, Joseph Py
Dorsey, Bruce Day
Application Number:
JP51685595A
Publication Date:
January 17, 2000
Filing Date:
December 12, 1994
Export Citation:
Assignee:
Merck End Company, Inc.
International Classes:
A61K31/495; A61P31/12; A61P31/18; A61P37/04; C07D241/04; C07D307/81; C07D405/06; C07D491/04; C07D491/048; C07D495/04; (IPC1-7): C07D307/81; A61P31/18; A61P43/00; A61K31/496; C07D491/048
Domestic Patent References:
| JP5279337A |
Attorney, Agent or Firm:
Yoshio Kawaguchi (3 outside)